| Year |
Citation |
Score |
| 2023 |
Ware MB, Phillips M, McQuinn C, Zaidi MY, Knochelmann HM, Greene E, Robinson BS, Herting CJ, Mace TA, Chen Z, Zhang C, Farren MR, Ruggieri AN, Bowers JS, Shakya R, et al. Dual IL-6 and CTLA-4 blockade regresses pancreatic tumors in a T cell and CXCR3-dependent manner. Jci Insight. PMID 36881480 DOI: 10.1172/jci.insight.155006 |
0.363 |
|
| 2020 |
Choueiry F, Torok M, Shakya R, Agrawal K, Deems A, Benner B, Hinton A, Shaffer J, Blaser BW, Noonan AM, Williams TM, Dillhoff M, Conwell DL, Hart PA, Cruz-Monserrate Z, ... ... Mace TA, et al. CD200 promotes immunosuppression in the pancreatic tumor microenvironment. Journal For Immunotherapy of Cancer. 8. PMID 32581043 DOI: 10.1136/Jitc-2019-000189 |
0.393 |
|
| 2019 |
Pinette A, McMichael E, Courtney NB, Duggan M, Benner BN, Choueiry F, Yu L, Abood D, Mace TA, Carson WE. An IL-15-based superagonist ALT-803 enhances the NK cell response to cetuximab-treated squamous cell carcinoma of the head and neck. Cancer Immunology, Immunotherapy : Cii. PMID 31338557 DOI: 10.1007/s00262-019-02372-2 |
0.311 |
|
| 2016 |
Pitarresi JR, Liu X, Sharma SM, Cuitiño MC, Kladney RD, Mace TA, Donohue S, Nayak SG, Qu C, Lee J, Woelke SA, Trela S, LaPak K, Yu L, McElroy J, et al. Stromal ETS2 Regulates Chemokine Production and Immune Cell Recruitment during Acinar-to-Ductal Metaplasia. Neoplasia (New York, N.Y.). 18: 541-52. PMID 27659014 DOI: 10.1016/J.Neo.2016.07.006 |
0.329 |
|
| 2016 |
Eng JW, Mace TA, Sharma R, Twum DY, Peng P, Gibbs JF, Pitoniak R, Reed CB, Abrams SI, Repasky EA, Hylander BL. Pancreatic cancer stem cells in patient pancreatic xenografts are sensitive to drozitumab, an agonistic antibody against DR5. Journal For Immunotherapy of Cancer. 4: 33. PMID 27330806 DOI: 10.1186/S40425-016-0136-Y |
0.454 |
|
| 2016 |
Stiff A, Trikha P, Wesolowski R, Kendra K, Hsu V, Uppati S, McMichael EL, Duggan M, Campbell A, Keller K, Landi I, Zhong Y, Dubovsky J, Howard JH, Yu L, ... ... Mace T, et al. Myeloid-derived suppressor cells express Bruton's tyrosine kinase and can be depleted in tumor bearing hosts by ibrutinib treatment. Cancer Research. PMID 26880800 DOI: 10.1158/0008-5472.Can-15-1490 |
0.31 |
|
| 2016 |
Ager C, Reilley M, Nicholas C, Bartkowiak T, Jaiswal A, Curran M, Albershardt TC, Bajaj A, Archer JF, Reeves RS, Ngo LY, Berglund P, ter Meulen J, Denis C, Ghadially H, ... ... Mace T, ... ... Mace T, ... ... Mace T, et al. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two Journal For Immunotherapy of Cancer. 4. DOI: 10.1186/S40425-016-0173-6 |
0.401 |
|
| 2015 |
Lesinski GB, Reville PK, Mace TA, Young GS, Ahn-Jarvis J, Thomas-Ahner J, Vodovotz Y, Ameen Z, Grainger E, Riedl K, Schwartz S, Clinton SK. Consumption of Soy Isoflavone Enriched Bread in Men with Prostate Cancer Is Associated with Reduced Proinflammatory Cytokines and Immunosuppressive Cells. Cancer Prevention Research (Philadelphia, Pa.). 8: 1036-44. PMID 26276751 DOI: 10.1158/1940-6207.Capr-14-0464 |
0.405 |
|
| 2015 |
Zynda ER, Grimm MJ, Yuan M, Zhong L, Mace TA, Capitano M, Ostberg JR, Lee KP, Pralle A, Repasky EA. a role for the thermal environment in defining co-stimulation requirements for cd4(+) t cell activation. Cell Cycle (Georgetown, Tex.). 0. PMID 26131730 DOI: 10.1080/15384101.2015.1049782 |
0.625 |
|
| 2014 |
Mace TA, King SA, Ameen Z, Elnaggar O, Young G, Riedl KM, Schwartz SJ, Clinton SK, Knobloch TJ, Weghorst CM, Lesinski GB. Bioactive compounds or metabolites from black raspberries modulate T lymphocyte proliferation, myeloid cell differentiation and Jak/STAT signaling. Cancer Immunology, Immunotherapy : Cii. 63: 889-900. PMID 24893859 DOI: 10.1007/S00262-014-1564-5 |
0.388 |
|
| 2014 |
Mace T, Shakya R, Swanson B, Ludwig T, Elnaggar O, Komar H, Yang J, Young G, Frankel W, Muscarella P, Bekaii-Saab T, Bloomston M, Lesinski G. BMS-911543 inhibits viability of tumor and stromal cells and limits disease progression in genetically engineered mice with pancreatic cancer Journal For Immunotherapy of Cancer. 2. DOI: 10.1186/2051-1426-2-S3-P186 |
0.327 |
|
| 2013 |
Mace TA, Ameen Z, Collins A, Wojcik S, Mair M, Young GS, Fuchs JR, Eubank TD, Frankel WL, Bekaii-Saab T, Bloomston M, Lesinski GB. Pancreatic cancer-associated stellate cells promote differentiation of myeloid-derived suppressor cells in a STAT3-dependent manner. Cancer Research. 73: 3007-18. PMID 23514705 DOI: 10.1158/0008-5472.Can-12-4601 |
0.413 |
|
| 2012 |
Capitano ML, Nemeth MJ, Mace TA, Salisbury-Ruf C, Segal BH, McCarthy PL, Repasky EA. Elevating body temperature enhances hematopoiesis and neutrophil recovery after total body irradiation in an IL-1-, IL-17-, and G-CSF-dependent manner. Blood. 120: 2600-9. PMID 22806894 DOI: 10.1182/Blood-2012-02-409805 |
0.667 |
|
| 2012 |
Lee CT, Zhong L, Mace TA, Repasky EA. Elevation in body temperature to fever range enhances and prolongs subsequent responsiveness of macrophages to endotoxin challenge. Plos One. 7: e30077. PMID 22253887 DOI: 10.1371/Journal.Pone.0030077 |
0.655 |
|
| 2012 |
Mace TA, Zhong L, Kokolus KM, Repasky EA. Effector CD8+ T cell IFN-γ production and cytotoxicity are enhanced by mild hyperthermia. International Journal of Hyperthermia : the Official Journal of European Society For Hyperthermic Oncology, North American Hyperthermia Group. 28: 9-18. PMID 22235780 DOI: 10.3109/02656736.2011.616182 |
0.743 |
|
| 2011 |
Mace TA, Zhong L, Kilpatrick C, Zynda E, Lee CT, Capitano M, Minderman H, Repasky EA. Differentiation of CD8+ T cells into effector cells is enhanced by physiological range hyperthermia. Journal of Leukocyte Biology. 90: 951-62. PMID 21873456 DOI: 10.1189/Jlb.0511229 |
0.652 |
|
| 2010 |
Lee CT, Mace T, Repasky EA. Hypoxia-driven immunosuppression: a new reason to use thermal therapy in the treatment of cancer? International Journal of Hyperthermia : the Official Journal of European Society For Hyperthermic Oncology, North American Hyperthermia Group. 26: 232-46. PMID 20388021 DOI: 10.3109/02656731003601745 |
0.64 |
|
| 2006 |
Mace TA, Yamane N, Cheng J, Hylander BL, Repasky EA. The potential of the tumor microenvironment to influence Apo2L/TRAIL induced apoptosis. Immunological Investigations. 35: 279-96. PMID 16916755 DOI: 10.1080/08820130600745463 |
0.612 |
|
| Show low-probability matches. |